114 related articles for article (PubMed ID: 8780035)
1. Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation.
Aksenov MY; Aksenova MV; Butterfield DA; Hensley K; Vigo-Pelfrey C; Carney JM
J Neurochem; 1996 May; 66(5):2050-6. PubMed ID: 8780035
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase.
Aksenov MYu ; Aksenova MV; Harris ME; Hensley K; Butterfield DA; Carney JM
J Neurochem; 1995 Oct; 65(4):1899-902. PubMed ID: 7561891
[TBL] [Abstract][Full Text] [Related]
3. Oxidative modification of glutamine synthetase by amyloid beta peptide.
Aksenov MY; Aksenova MV; Carney JM; Butterfield DA
Free Radic Res; 1997 Sep; 27(3):267-81. PubMed ID: 9350431
[TBL] [Abstract][Full Text] [Related]
4. alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity.
Aksenova MV; Aksenov MY; Butterfield DA; Carney JM
Neurosci Lett; 1996 Jun; 211(1):45-8. PubMed ID: 8809844
[TBL] [Abstract][Full Text] [Related]
5. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
Hensley K; Carney JM; Mattson MP; Aksenova M; Harris M; Wu JF; Floyd RA; Butterfield DA
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3270-4. PubMed ID: 8159737
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures.
Lockhart BP; Benicourt C; Junien JL; Privat A
J Neurosci Res; 1994 Nov; 39(4):494-505. PubMed ID: 7533847
[TBL] [Abstract][Full Text] [Related]
7. Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide.
Shen CL; Scott GL; Merchant F; Murphy RM
Biophys J; 1993 Dec; 65(6):2383-95. PubMed ID: 8312477
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity.
Aksenov MY; Aksenova MV; Carney JM; Butterfield DA
Neurosci Lett; 1996 Oct; 217(2-3):117-20. PubMed ID: 8916086
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid beta-peptide (1-42).
Butterfield DA; Yatin SM; Link CD
Ann N Y Acad Sci; 1999; 893():265-8. PubMed ID: 10672245
[No Abstract] [Full Text] [Related]
10. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction.
Gray CW; Patel AJ
Brain Res; 1995 Sep; 691(1-2):169-79. PubMed ID: 8590049
[TBL] [Abstract][Full Text] [Related]
11. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
12. Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity.
Kanski J; Varadarajan S; Aksenova M; Butterfield DA
Biochim Biophys Acta; 2002 Mar; 1586(2):190-8. PubMed ID: 11959460
[TBL] [Abstract][Full Text] [Related]
13. Entactin-induced inhibition of human amyloid beta-protein fibril formation in vitro.
Kiuchi Y; Isobe Y; Fukushima K
Neurosci Lett; 2001 Jun; 305(2):119-22. PubMed ID: 11376898
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective interactions of peptide inhibitors with the beta-amyloid peptide.
Chalifour RJ; McLaughlin RW; Lavoie L; Morissette C; Tremblay N; Boulé M; Sarazin P; Stéa D; Lacombe D; Tremblay P; Gervais F
J Biol Chem; 2003 Sep; 278(37):34874-81. PubMed ID: 12840031
[TBL] [Abstract][Full Text] [Related]
15. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
[TBL] [Abstract][Full Text] [Related]
16. Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.
Yatin SM; Aksenova M; Aksenov M; Markesbery WR; Aulick T; Butterfield DA
J Mol Neurosci; 1998 Dec; 11(3):183-97. PubMed ID: 10344789
[TBL] [Abstract][Full Text] [Related]
17. Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-β.
Sugiki T; Utsunomiya-Tate N
Biochem Biophys Res Commun; 2013 Nov; 441(2):493-8. PubMed ID: 24383085
[TBL] [Abstract][Full Text] [Related]
18. On the mechanism of the inhibition of glutamine synthetase and creatine phosphokinase by methionine sulfoxide.
Haghighi AZ; Maples KR
J Neurosci Res; 1996 Jan; 43(1):107-11. PubMed ID: 8838581
[TBL] [Abstract][Full Text] [Related]
19. The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.
Butterfield DA; Boyd-Kimball D
Biochim Biophys Acta; 2005 Jan; 1703(2):149-56. PubMed ID: 15680223
[TBL] [Abstract][Full Text] [Related]
20. Aggregation and neurotoxicity of mutant amyloid beta (A beta) peptides with proline replacement: importance of turn formation at positions 22 and 23.
Morimoto A; Irie K; Murakami K; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
Biochem Biophys Res Commun; 2002 Jul; 295(2):306-11. PubMed ID: 12150948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
